Analysis of systemic serum vancomycin levels following intraarticular application in primary total joint arthroplasty
2024

Vancomycin Levels After Joint Surgery

Sample size: 103 publication Evidence: moderate

Author Information

Author(s): R Stauss, P Savov, GH Seeber, S Brand, M Ettinger, JA Beheshty

Primary Institution: Carl von Ossietzky Universität Oldenburg

Hypothesis

The topical application of vancomycin powder would not result in systemic vancomycin levels within the therapeutic range.

Conclusion

Intraarticular administration of vancomycin powder did not result in systemic vancomycin levels within the therapeutic range, indicating it may be a safe adjunct for preventing periprosthetic joint infection.

Supporting Evidence

  • No systemic vancomycin levels within the therapeutic range were detected.
  • Mean serum vancomycin levels were significantly higher in the THA cohort compared to TKA.
  • The overall PJI rate was 0.0% at a mean follow-up of 5–6 months.

Takeaway

Doctors used a special powder during joint surgery to help prevent infections, and it didn't show harmful levels in the patients' blood.

Methodology

This was a prospective pilot study measuring serum vancomycin levels at 24 and 48 hours post-surgery in patients receiving intraarticular vancomycin powder.

Limitations

The study had a small sample size and limited follow-up duration of 6 months.

Participant Demographics

64% female, mean age 68.5 years.

Statistical Information

P-Value

p<0.001 for 24h, p=0.044 for 48h

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s00402-024-05688-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication